Daewoong Pharmaceutical Co. LTD.: all 225 studies

Page 3 of 3. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• Clinical Study for Patients With Hypertension Associated With DyslipidemiaCompletedNCT01764295Phase 3
• Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male VolunteersCompletedNCT01653314Phase 1
• Nurigra Chewable Tablet in Healthy Adult Male VolunteersCompletedNCT01651858Phase 1
• Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01636401Phase 3
• Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male VolunteersStatus unknownNCT01635686Phase 1
• The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious PubertyCompletedNCT01634321Phase 4
• Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor AugmentationCompletedNCT01634308Phase 3
• Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar LineCompletedNCT01629875Phase 3
• Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel SyndromeStatus unknownNCT01629212Phase 4
• Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic MellitusCompletedNCT01629199Phase 3
• Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic DermatitisCompletedNCT01568489Phase 2
• Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic NeuralgiaCompletedNCT01557010Phase 2
• Efficacy and Safety of HL-040XC in Essential Hypertension and HyperlipidemiaCompletedNCT01541943Phase 3
• Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031TerminatedNCT01522586Phase 1
• Efficacy and Safety Study of ELIGARD 22.5mg With Prostate CancerCompletedNCT01511874Phase 4
• A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276CompletedNCT01493856Phase 1
• Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male VolunteersCompletedNCT01440686Phase 1
• A Single Dose Study of DWP10292 in Healthy Male SubjectsCompletedNCT01423526Phase 1
• Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersCompletedNCT01415466Phase 1
• The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in PatientsStatus unknownNCT01397240Phase 4
• A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CCompletedNCT01194037Phase 1/2
• The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy PatientsStatus unknownNCT01099891Phase 3
• Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride MedicineCompletedNCT01094847Phase 1
• A Multiple Dose Study of DWP05195 in Healthy Adult SubjectsCompletedNCT01094834Phase 1
• DWP05195 in Healthy Adult Male VolunteersCompletedNCT00969787Phase 1

← Daewoong Pharmaceutical Co. LTD. overview and focus areas